ADMA Biologics 2024年第四季度 GAAP 每股收益 $0.46,销售额 $117.549M 超过预期 $112.800M

财报速递
Mar 04, 2025
ADMA Biologics 2024年第四季度 GAAP 每股收益 $0.46,销售额 $117.549M 超过预期 $112.800M

以上内容来自Benzinga Earnings专栏,原文如下:

ADMA Biologics Q4 2024 GAAP EPS $0.46, Sales $117.549M Beat $112.800M Estimate

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10